AstraZeneca ends R&D in India


Pharmaceutical firm AstraZeneca (AZ) is quitting its R&D site in Bangalore, India. The closure means 168 employees, researching neglected tropical diseases, tuberculosis (TB) and malaria, will lose their jobs as AZ drops its early-stage research into these areas.

The company will retain more advanced projects, such as AZD5847, which is in Phase II trials against TB. It will also outsource the site’s current product development functions, or transfer them to Macclesfield, UK. However, AZ confirmed it will maintain access to its compound library for open innovation projects in neglected diseases.

The closure is part of AZs ongoing restructuring programme, which began last year, will cost a total of 1600 jobs worldwide and see the company’s main UK R&D activities move from Alderley Park to Cambridge. After the closure, AZ will have just over 1000 staff in India, across manufacturing, sales and marketing roles.


Related Content

Global AstraZeneca restructuring will cost 1600 jobs

19 March 2013 Business

news image

Firm will focus drug development efforts in three strategic R&D centres in the UK, Sweden and the US

Generation next

29 January 2014 Educated Chemist

news image

AstraZeneca is investing in the future of drug discovery with its new graduate training scheme in pharma. Manisha Lalloo find...

Most Read

Isotope effect produces new type of chemical bond

22 October 2014 Research

news image

Evidence emerges for vibrational bond first proposed 30 years ago

DNA 'barcodes' used to track food

30 October 2014 Research

news image

Milk has been successfully tracked as it is turned into cheese and yogurt in an advance that could fight food fraud

Most Commented

Square planar iron complex breaks inorganic dogma

31 October 2014 Research

news image

Unusual spin state could open the door to new and exciting chemistry

Indian U-turn on diabetes drug ban

16 August 2013 News and Analysis

news image

Suspension of cheap and popular medicine reversed but will now come with new safety warnings